The Patent Finder

Crystalline Forms of a Prolyl Hydroxylase Inhibitor

Kyntra Bio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/672,191, filed Jul 16, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,883,823Crystalline Forms of a Prolyl Hydroxylase Inhibitor
In force
 · High confidence
UsedRemaining
Kyntra Bio, Inc.In forceHigh confidence
US 9,115,085Crystalline Forms of a Prolyl Hydroxylase Inhibitor
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
US 9,371,288Crystalline Forms of a Prolyl Hydroxylase Inhibitor
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
US 9,617,218Crystalline Forms of a Prolyl Hydroxylase Inhibitor
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
US 9,918,977Crystalline Forms of a Prolyl Hydroxylase Inhibitor
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
US 10,118,897Crystalline Forms of a Prolyl Hydroxylase Inhibitor
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
US 10,272,078Crystalline Forms of a Prolyl Hydroxylase Inhibitor
In force
 · High confidence
Kyntra Bio, Inc.In forceHigh confidence
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited